Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0175292 Antioxidants Having Aromatic Structures Reacting with Superoxide
Disclosed is a method of treating diseases which are: reactive oxygen species mediated, ischemic or reperfusion-related, or T-cell mediated, including...
2016/0175291 SUPRESSION OF IGE PRODUCTION BY COMPOUNDS DERIVED FROM TRADITIONAL CHINESE MEDICINE
The present invention relates to compounds and formulations derived from traditional Chinese medicine for use for the treatment and/or mediation of food...
2016/0175290 BETA-LACTAMASE INHIBITOR COMPOUNDS
The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in...
2016/0175289 TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
Described herein are tetrahydro-pyrido[3,4-b]indol-1-yl compounds with estrogen receptor modulation activity or function having the Formula I structure: ...
2016/0175288 MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
The present invention provides a device for intracorporeal use including an implant or a temporary device and at least one source of a compound myolimus, or a...
2016/0175287 ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
Described herein is a novel class of inhibitors of bacterial cell division. Several lines of evidence suggest the compounds disclosed herein specifically...
2016/0175286 SELECTIVE AT2 RECEPTOR AGONISTS FOR USE IN TREATMENT OF CACHEXIA
The present invention is directed to selective AT2 receptor agonist or a pharmaceutically acceptable salt thereof for use in treatment of cachexia, preferably...
2016/0175285 DEXMEDETOMIDINE PREMIX FORMULATION
The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein...
2016/0175284 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
Described herein are compounds that are estrogen receptor modulators of Formula I: ##STR00001## and stereoisomers, tautomers, or pharmaceutically ...
2016/0175283 OXYTOCIN RECEPTOR ANTAGONIST THERAPY IN THE LUTEAL PHASE FOR IMPLANTATION AND PREGNANCY IN WOMEN UNDERGOING...
The present invention relates to the use of an oxytocin receptor antagonist in females undergoing embryo transfer as part of an assisted reproductive...
2016/0175282 SPHINGOSINE 1 PHOSPHATE RECEPTOR MODUATORS AND THEIR USE TO TREAT MUSCLE INFLAMMATION
SIP receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the...
2016/0175281 IMMUNOSUPPRESSIVE COMPOUNDS AND THERAPEUTICS
Here provided are new immunosuppressive compounds and novel therapeutics for improving tissue transplantation.
2016/0175280 COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION, FOR PROMOTING ELASTIN PRODUCTION AND/OR FOR PROMOTING...
The present invention relates to a composition for enhancing collagen production, for enhancing elastin production and/or for enhancing keratinocyte migration,...
2016/0175279 METHOD OF TREATING NEURODEGENERATIVE DISORDERS
The present disclosure is directed, at least in part, to disease-modifying treatments for neurodegenerative disorders. In one embodiment, a method of delaying...
2016/0175278 ARYL HYDROCARBON RECEPTOR (AhR) MODIFIERS AS NOVEL CANCER THERAPEUTICS
Provided herein are novel agents that modulate AhR activity for use in therapeutic compositions and methods thereof for inhibiting cancer cell proliferation...
2016/0175277 METHOD OF TREATMENT FOR ENHANCING EXERCISE PERFORMANCE
Provided is a composition containing myricetin or a pharmaceutically available salt thereof as an active ingredient. The composition increases exercise...
2016/0175276 NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described...
2016/0175275 METHOD OF TREATING OR PREVENTING RAS-MEDIATED DISEASES
Disclosed are compounds, for example, a compound of formula I, ##STR00001## wherein R, R.sub.0, R.sub.1-R.sub.8, n, X, Y, Y', and E are as described herein,...
2016/0175274 TREATING AN ATYPICAL PROTEIN KINASE C ENZYME ABNORMALITY
Provided herein are compounds, compositions, pharmaceutical formulations, methods of treating and methods of using aPKC inhibitors for treating and/or...
2016/0175273 MICROORGANISMS THAT EXTRACELLULARLY SECRETE LIPIDS AND METHODS OF PRODUCING LIPID AND LIPID PARTICLES...
There are provided microorganisms having a property of producing a lipid containing unsaturated fatty acids as constituent fatty acids and extracellularly...
2016/0175272 COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION
The present invention is directed to novel anti-inflammatory immunomodulators including creatinine or a creatinine salt, for example, creatinine hydrochloride....
2016/0175271 RECTAL SUPPOSITORY FOR ULCERATIVE COLITIS
A rectal suppository comprising mesalamine and a corticosteroid is provided. The suppository contains a suppository base, at least one surfactant and at least...
2016/0175270 RECTAL SUPPOSITORY FOR ULCERATIVE COLITIS
A rectal suppository comprising mesalamine and a local anaesthetic agent is provided. The suppository contains a suppository base, at least one surfactant and...
2016/0175269 CRYSTALLINE FORMS OF BIMATOPROST ACID, METHODS FOR PREPARATION, AND METHODS FOR USE THEREOF
The invention provides new crystalline forms of 7-[3,5-Dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-hept-5-e- noic acid. This compound is commonly...
2016/0175268 MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS
A composition for administration to a subject, such as oral administration to a subject, for example, has been provided. Such a composition may comprise at...
2016/0175267 SYSTEMS AND METHODS FOR BIO-MATCHING GELS, CREAMS AND LOTIONS
A method of bio-matching a topical gel, cream or lotion may comprise selecting a vagina of a living body, identifying a secretion of the selected vagina,...
2016/0175266 NMDA RECEPTOR ANTAGONIST FORMULATION WITH REDUCED NEUROTOXICITY
The present invention is directed to pharmaceutical compositions of effective amounts of NMDA receptor antagonists and preservative for the administration to a...
2016/0175265 REACTIVE OXYGEN SPECIES (ROS)-RESPONSIVE COMPOSITIONS AND METHODS THEREOF
A reactive oxygen species savaging emulsion; the emulsion comprising an injectable pharmaceutically acceptable composition and a polymeric poly(propylene...
2016/0175264 COMPOSITIONS AND METHODS USING P-ANISALDEHYDE
Compositions contain a therapeutically effective amount of p-anisaldehyde for at least one of provoking the swallowing reflex of dysphagic patients, decreasing...
2016/0175263 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS, METHOD FOR PREVENTING OR TREATING...
Provided are a pharmaceutical composition including geraniol or a pharmaceutically acceptable salt thereof as an active ingredient for use in preventing or...
2016/0175262 Gel Patch
A gel patch includes a base fabric, an adhesive layer, and a release liner in this order, wherein the adhesive layer contains a physiologically active...
2016/0175261 METHODS AND COMPOSITIONS FOR MODIFYING MUCOUS MEMBRANES
The present invention relates to methods and compositions for modifying mucous membranes. In particular, the present invention relates to treating diseases...
2016/0175260 PROTEASE ASSISTED NATIVE-PROTEIN DELIVERY APPROACH (PANDA)
A method for intracellular delivery of single proteins or other cargo molecules by encapsulation within nanocapsules formed by interfacial polymerization of...
2016/0175259 Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes
Disclosed herein are nanoparticle, micelle and/or liposome compositions, each comprising a therapeutic agent encapsulated in one or more polymer(s), wherein a...
2016/0175258 SOFT CAPSULE SHELL
Provided are a plant-derived soft capsule shell having a high shell sheet strength, a good adhesive property, and excellent shell performance, and a soft...
2016/0175257 SOLID ORAL DOSAGE FORM OF METHYLPHENIDATE OR SALTS THEREOF
A solid oral dosage form of methylphenidate or salts thereof which provide a rapid initial onset of action and a prolonged duration of effect is provided. The...
2016/0175256 ABUSE-PROOFED ORAL DOSAGE FORM
The present invention relates to an abuse-proofed, oral dosage form with controlled opioid-release for once daily administration, characterised in that it...
2016/0175255 DEFERACIROX DISPERSIBLE TABLETS
The invention pertains to dispersible tablets comprising as active ingredient 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid or pharmaceutically...
2016/0175254 THE SYNTHESIS OF CORE-SHELL METAL-SEMICONDUCTOR NANOMATERIALS
A solution-based route to biocompatible, cysteine-capped gold-zinc telluride (Au--ZnTe) core/shell nanoparticles with potential in biomedical applications is...
2016/0175253 APPLICATION OF ANDROGRAPHOLIDE IN THE PREPARATION OF A PHARMACEUTICAL FOR TREATMENT OF INFLAMMATORY BOWEL...
The present invention relates to an andrographolide enteric targeting micropellet and a method for preparation thereof; furthermore, the present invention also...
2016/0175252 OXIDIZED CELLULOSE MICROSPHERES
A process for forming microspheres is disclosed. The process includes contacting a solvent with a modified cellulose to form a solution; contacting the...
2016/0175251 YEAST CELL WALL PARTICLES FOR RECEPTOR-TARGETED NANOPARTICLE DELIVERY
The present invention generally relates to yeast cell wall microparticles loaded with nanoparticles for receptor-targeted nanoparticle delivery. In particular,...
2016/0175250 Method for Making Liposomes Containing an Active Pharmaceutical Ingredient
A method for size reduction of liposomes that may be used for administration of a drug into the body of an individual in which the size reduction method is by...
2016/0175249 Liposomes Containing Oligopeptide Fragments of Myelin Basic Protein, a Pharmaceutical Composition and a Method...
A composition for the treatment of multiple sclerosis comprises a first myelin basic protein (MBP) peptide linked to a first vector, the first MBP peptide...
2016/0175248 Omega-3 Fatty Acid Ester Compositions Unitary Pharmaceutical Dosage Forms
Described herein are compositions comprising at least one Omega-3 fatty acid ester and at least one surface active agent; wherein the compositions form...
2016/0175247 COMPOSITION CONTAINING POLYCATIONIC TRIBLOCK COPOLYMER, POLYANIONIC POLYMER AND PHYSIOLOGICALLY ACTIVE PEPTIDE
[Problem] To provide a physiologically active peptide-loaded stable composition for injection into living bodies. [Solution] A composition containing a triblock...
2016/0175246 PHARMACEUTICAL FORMULATIONS
Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and...
2016/0175245 TREATMENT OF DISEASES ASSOCIATED WITH MOLD AND MYCOTOXIN EXPOSURE
A method of treating disease states associated with mold and mycotoxin , resulting in illnesses such as Chronic Fatigue Syndrome (CFS), Gulf War Syndrome...
2016/0175244 COMPOSITIONS FOR TOPICAL TREATMENT OF MICROBIAL INFECTIONS
The present invention provides compositions and methods for topical treatment of infections. The compositions comprise glycerol monolaurate or a derivative...
2016/0175243 NANOROD MATERIALS AND METHODS OF MAKING AND USING SAME
The subject invention concerns nanorods, compositions and substrates comprising nanorods, and methods of making and using nanorods and nanorod compositions and...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.